| 1 |
33119328 | GPR52 agonists attenuate ropinirole-induced preference for uncertain outcomes. | 2021 Feb |
1 |
| 2 |
33249031 | Genetic suppression of the dopamine D3 receptor in striatal D1 cells reduces the development of L-DOPA-induced dyskinesia. | 2021 Feb |
1 |
| 3 |
29936243 | Behavioral and cellular dopamine D1 and D3 receptor-mediated synergy: Implications for L-DOPA-induced dyskinesia. | 2018 Aug |
1 |
| 4 |
25914172 | Coadministration of hydroxysafflor yellow A with levodopa attenuates the dyskinesia. | 2015 Aug 1 |
1 |
| 5 |
20850462 | Evaluation of the D3 dopamine receptor selective agonist/partial agonist PG01042 on L-dopa dependent animal involuntary movements in rats. | 2011 Feb-Mar |
1 |
| 6 |
19118628 | Dopamine D3 receptor stimulation underlies the development of L-DOPA-induced dyskinesia in animal models of Parkinson's disease. | 2009 Aug |
1 |
| 7 |
19371585 | Evaluation of the D3 dopamine receptor selective antagonist PG01037 on L-dopa-dependent abnormal involuntary movements in rats. | 2009 May-Jun |
1 |
| 8 |
17241287 | Concomitant short- and long-duration response to levodopa in the 6-OHDA-lesioned rat: a behavioural and molecular study. | 2007 Jan |
1 |
| 9 |
16814282 | Actions at sites other than D(3) receptors mediate the effects of BP897 on l-DOPA-induced hyperactivity in monoamine-depleted rats. | 2006 Nov |
2 |
| 10 |
14697317 | Ropinirole versus L-DOPA effects on striatal opioid peptide precursors in a rodent model of Parkinson's disease: implications for dyskinesia. | 2004 Jan |
1 |
| 11 |
12535962 | Effects of oligonucleotide antisense to dopamine D3 receptor mRNA in a rodent model of behavioural sensitization to levodopa. | 2003 |
3 |
| 12 |
14623353 | Brain-derived neurotrophic factor controls dopamine D3 receptor expression: therapeutic implications in Parkinson's disease. | 2003 Nov 7 |
3 |
| 13 |
10886351 | Involvement of the direct striatonigral pathway in levodopa-induced sensitization in 6-hydroxydopamine-lesioned rats. | 2000 Jun |
1 |
| 14 |
9096399 | Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa. | 1997 Apr 1 |
1 |